Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Avoralstat

Copy Product Info
😃Good
Catalog No. T14358Cas No. 918407-35-9
Alias BCX4161

Avoralstat (BCX4161) is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.

Avoralstat

Avoralstat

Copy Product Info
😃Good
Purity: 99.77%
Catalog No. T14358Alias BCX4161Cas No. 918407-35-9
Avoralstat (BCX4161) is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$29In StockIn Stock
5 mg$68In StockIn Stock
10 mg$98In StockIn Stock
25 mg$198In StockIn Stock
50 mg$317In StockIn Stock
100 mg$461-In Stock
1 mL x 10 mM (in DMSO)$77In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.77%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Avoralstat AI Summary
Avoralstat is a potent inhibitor of purified human plasma kallikrein, with a Ki value of 0.26 nM. It demonstrates significant selectivity towards human trypsin compared to human plasma kallikrein, with a high selectivity index as evidenced by a Ratio IC50 of 8192.0. The compound also exhibits good solubility, with values of 47000.0 ug.mL-1 at pH 4 and 1090.0 ug.mL-1 at pH 7..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Avoralstat (BCX4161) is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
SynonymsBCX4161
Chemical Properties
Molecular Weight513.54
FormulaC28H27N5O5
Cas No.918407-35-9
SmilesCOc1cc(c(cc1C=C)C(=O)Nc1ccc(cc1)C(N)=N)-c1ccc(nc1C(O)=O)C(=O)NCC1CC1
Relative Density.1.38 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (97.36 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.89 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9473 mL9.7363 mL19.4727 mL97.3634 mL
5 mM0.3895 mL1.9473 mL3.8945 mL19.4727 mL
10 mM0.1947 mL0.9736 mL1.9473 mL9.7363 mL
20 mM0.0974 mL0.4868 mL0.9736 mL4.8682 mL
50 mM0.0389 mL0.1947 mL0.3895 mL1.9473 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Avoralstat | purchase Avoralstat | Avoralstat cost | order Avoralstat | Avoralstat chemical structure | Avoralstat formula | Avoralstat molecular weight